| | Identification | Back Directory |  | [Name] 
 Jujuboside B
 |  | [CAS] 
 55466-05-2
 |  | [Synonyms] 
 Jujuboside
 JUJUBOSIDE B
 Jujuboside B 55466-05-2
 Wild jujube seed extract
 JUJUBOSIDE B, 98.0% BY HPLC
 2)-O-[O-b-D-xylopyranosyl-(1®
 xylopyranosyl-(1→2)-β-D-glucopyranosyl-(1→3)]-
 JUJUBOSIDE, A+B ≥2% BY UV FROM JUJUBA PLANT EXTRACT
 Jujuboside B, 98%, from Ziziphus jujuba Mill.var.spinosa
 (16S,20S,23R)-16,23:16,30-Diepoxy-3β-[2-O-(6-deoxy-α-L-mannopyranosyl)-3-O-[2-O-(β-D-xylopyranosyl)-β-D-glucopyranosyl]-α-L-arabinopyranosyloxy]-5α-dammar-24-en-20-ol
 α-L-Arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[O-β-D-xylopyranosyl-(1→2)-β-D-glucopyranosyl-(1→3)]-
 o-6-deoxy-a-l-mannopyranosyl-(1(r)2)-o-[o-b-d-xylopyranosyl-(1(r)2)-b-d-glucopyranosyl-(1(r)3)]-(3b,16b,23r)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl-a-l-arabinopyranoside
 |  | [Molecular Formula] 
 C52H84O21
 |  | [MDL Number] 
 MFCD03427710
 |  | [MOL File] 
 55466-05-2.mol
 |  | [Molecular Weight] 
 1045.21
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 228-231°C
 |  | [density ] 
 1.44
 |  | [storage temp. ] 
 2-8°C
 |  | [solubility ] 
 Soluble in ethanol and pyridine
 |  | [form ] 
 powder
 |  | [pka] 
 12.84±0.70(Predicted)
 |  | [color ] 
 White
 |  | [biological source] 
 plant (Semen Ziziphus spinosa)
 |  | [InChIKey] 
 GFOFQZZEGDPXTG-ZHUYPZMKSA-N
 | 
 | Hazard Information | Back Directory |  | [Chemical Properties] 
 White crystalline powder, easily soluble in methanol, almost insoluble in ether, derived from sour jujube seeds.
 |  | [Definition] 
 ChEBI: Jujuboside B is a triterpenoid.
 |  | [Biological Activity] 
 Jujuboside B  is known for its treatment of insomnia and anxiety and has been reported to have activities relevant to the cardiovascular system. Jujuboside B inhibits platelet aggregation and is considered as a preventive drug for platelet-based cardiovascular diseases.
 Jujuboside B as food supplementhas neurobeneficial effects and could be a potential drug candidate for treating neurodegenerative diseases.
 | 
 |  |